Drug induced liver injury prevention: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) m (YazanDaaboul moved page Drug induced liver injury primary prevention to Drug induced liver injury prevention) |
m (Template) |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Drug induced liver injury}} | {{Drug induced liver injury}} | ||
{{CMG}} {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
==Prevention== | |||
==Primary Prevention== | |||
==Secondary Prevention== | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
Revision as of 13:58, 3 August 2016
|
Drug induced liver injury Microchapters |
|
Differentiating Drug Induced Liver Injury from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Drug Induced Liver Injury On the Web |
|
American Roentgen Ray Society Images of Drug induced liver injury |
|
Risk calculators and risk factors for Drug induced liver injury |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: